Systematic identification of signaling pathways with potential to confer anticancer drug resistanceColin A. Martz, Kris C. Wood, Lawrence N. Kwong et al.|Science Signaling|2014Cited by 199
Targeting MCL-1/BCL-XL Forestalls the Acquisition of Resistance to ABT-199 in Acute Myeloid LeukemiaKevin Lin, Kris C. Wood, Peter Winter et al.|Scientific Reports|2016Cited by 178
Mediator kinase inhibition impedes transcriptional plasticity and prevents resistance to ERK/MAPK-targeted therapy in KRAS-mutant cancersDaniel P. Nussbaum, Kris C. Wood, Colin A. Martz et al.|npj Precision Oncology|2024Cited by 6
Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in <i>KRAS</i> -Mutant CancersDaniel P. Nussbaum, Kris C. Wood, Colin A. Martz et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1
Mediator Kinase Inhibition Impedes Transcriptional Plasticity and Prevents Resistance to ERK/MAPK-Targeted Therapy in KRAS-Mutant CancersKris C. Wood, Dylan J. Taatjes, Daniel P. Nussbaum et al.|Research Square|2023Cited by 0